docetaxel manufacturer

Product Name :
Chemical Formula :
1,7?,10?-trihydroxy-9-oxo-5?,20-epoxytax-11-ene-2?,4,13?-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
CAS No :
Molecular Formula :
Molecular Weight :
Description :
Docetaxel is a clinically well-established anti-mitotic chemotherapy medication (that is, it interferes with cell division). It is used mainly for the treatment of breast, ovarian, prostate, and non-small cell lung cancer. Docetaxel has been used for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed and for use in hormone-refractory prostate cancer. Docetaxel is considered as or more effective than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule agent.

Submit Enquiry